Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT06112314
Title IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301) (PRISM-MEL-301)
Acronym PRISM-MEL-301
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Immunocore Ltd
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | AUS


No variant requirements are available.